Literature DB >> 12751910

Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme-substrate interactions.

David F V Lewis1, Brian G Lake, Maurice Dickins, Peter S Goldfarb.   

Abstract

The results of homology modelling of CYP2B6 based on the CYP2C5 crystal structure is described in terms of substrates and inhibitors binding within the putative active site. In general these results are in agreement with currently available evidence from substrate metabolism, mode of inhibitor action and site-directed mutagenesis experiments within the CYP2B subfamily of enzymes. Consequently, the model based on the CYP2C5 template represents an advance on those models produced from bacterial P450s, such as CYP101 and CYP102. Quantitative Structure-Activity Relationships (QSARs) for substrates binding to CYP2B6 indicate a key role for hydrogen bonding, and lipophilic character, as determined by the log P parameter (where P is the octanol/water partition coefficient), is also of importance for explaining the variation in experimental binding affinity for CYP2B6 substrates. It is possible to estimate the binding energies for typical CYP2B6 substrates based on their properties and interactions with the enzyme, which show good concordance with experimental data in the form of apparent Km values.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12751910     DOI: 10.1515/dmdi.2002.19.2.115

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  1 in total

Review 1.  Utility of homology models in the drug discovery process.

Authors:  Alexander Hillisch; Luis Felipe Pineda; Rolf Hilgenfeld
Journal:  Drug Discov Today       Date:  2004-08-01       Impact factor: 7.851

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.